CD14 and Sepsis: Therefore, applying a combined inhibition therapy targeting complement factor C5 and the CD14 (C5/CD14 inhibition) is of interest since their simultaneous inhibition improved the outcome of sepsis by reducing the expression of inflammatory cytokines, such as IL-1β, IL-6, TNF and CXCL1 (14).